Bilateral Multifocal Central Serous-Like Chorioretinopathy due to MEK Inhibition for Metastatic Cutaneous Melanoma

Newer chemotherapeutic agents target extracellular signaling, including the mitogen-activated protein kinase kinase (MEK) pathway. We present a case of a 54-year-old female who developed bilateral multifocal central serous-like chorioretinopathy shortly after starting MEK inhibition for metastatic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoenberger, Scott D., Kim, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608121/
https://www.ncbi.nlm.nih.gov/pubmed/23555064
http://dx.doi.org/10.1155/2013/673796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608121/
https://www.ncbi.nlm.nih.gov/pubmed/23555064
http://dx.doi.org/10.1155/2013/673796

Ejemplares similares